Edition:
United States

Opiant Pharmaceuticals Inc (OPNT.OQ)

OPNT.OQ on NASDAQ Stock Exchange Capital Market

23.50USD
14 Dec 2017
Change (% chg)

$-0.61 (-2.53%)
Prev Close
$24.11
Open
$24.10
Day's High
$24.50
Day's Low
$21.35
Volume
38,503
Avg. Vol
--
52-wk High
$51.90
52-wk Low
$21.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Oct 0.02 -2.772
FY 2017 Jul '17 3.77 -0.166
Apr '17 0.02 -1.554
Jan '17 13.53 4.908
Oct 1.12 -0.301
FY 2016 Jul '16 0.31 -0.546
Apr '16 2.61 0.152
Jan '16 6.86 1.524
Oct 0.12 -6.005
FY 2015 Jul '15 0.87 -0.889
Apr '15 0.12 -1.011
Jan '15 0.56 -1.537
Oct 0.00 -0.434
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 56.39 32.50 36.03
P/E High - Last 5 Yrs. 4.42 40.74 45.26
P/E Low - Last 5 Yrs. 4.42 23.65 24.26
Beta -0.46 0.92 0.91
Price to Sales (TTM) 2.80 3.97 5.90
Price to Book (MRQ) 1,041.10 4.92 5.74
Price to Tangible Book (MRQ) 1,675.70 5.79 7.33
Price to Cash Flow (TTM) -- 23.36 24.72
% Owned Institutions 2.94 0.85 1.38

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.48
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.28 5.23
Payout Ratio(TTM) 0.00 47.43 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -98.04 6.29 6.77
Sales (TTM) vs TTM 1 Yr. Ago 59.16 5.09 5.56
Sales - 5 Yr. Growth Rate -- 10.01 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -819.41 7.08 7.88
EPS (TTM) vs TTM 1 Yr. Ago -49.68 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.92
Capital Spending - 5 Yr. Growth Rate -- 15.14 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 1.56 3.51 3.57
LT Debt to Equity (MRQ) 0.00 10.90 13.26
Total Debt to Equity (MRQ) 0.00 16.99 19.22
Interest Coverage (TTM) 31.57 49.07 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.21 54.87
Gross Margin - 5 Yr. Avg. -- 52.33 52.44
EBITD Margin (TTM) 11.94 -- --
EBITD - 5 Yr. Avg -92.47 18.52 15.70
Operating Margin (TTM) 11.72 14.76 6.77
Operating Margin - 5 Yr. Avg. -92.51 14.36 11.08
Pre-Tax Margin (TTM) 12.10 15.22 7.60
Pre-Tax Margin - 5 Yr. Avg. -94.94 14.67 11.49
Net Profit Margin (TTM) 8.93 11.39 3.83
Net Profit Margin - 5 Yr. Avg. -96.78 11.00 7.78
Effective Tax Rate (TTM) 26.23 24.37 24.27
Effective Tax Rate - 5 Yr. Avg. -- 23.47 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 951,233,490 857,902,259
Net Income/Employee (TTM) -- 111,321,846 100,310,105
Receivable Turnover (TTM) 49.62 5.91 6.13
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 3.95 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 35.29 11.90 11.35
Return on Assets - 5 Yr. Avg. -331.03 12.90 12.32
Return on Investment (TTM) -- 15.11 14.48
Return on Investment - 5 Yr. Avg. -- 16.87 16.13
Return on Equity (TTM) -- 16.59 16.06
Return on Equity - 5 Yr. Avg. -- 17.87 17.32
  1 Year 3 Year 5 Year
Sales % 86.37 -- --
EPS (TTM) % 171.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Opiant Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.94%
# of Holders: 11
Total Shares Held: 60,896
3 Mo. Net Change: 34,046
# New Positions: 10
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 0
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.